Orbimed Advisors LLC Bristol Myers Squibb CO Transaction History

Orbimed Advisors LLC

$4.15 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $54.3 Million - $60.3 Million	-852,000 Reduced 36.41%	1,488,000 $95.2 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $16.1 Million - $18.3 Million	-244,900 Reduced 9.47%	2,340,000 $162 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $8,606 - $5.09 Million	66,200 Added 2.63%	2,584,900 $184 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $6.46 Million - $7.12 Million	-89,000 Reduced 3.41%	2,518,700 $194 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $106 Million - $128 Million	-1,732,100 Reduced 39.91%	2,607,700 $190 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $9.42 Million - $11 Million	-175,600 Reduced 3.89%	4,339,800 $271 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $57.3 Million - $64.5 Million	966,300 Added 27.23%	4,515,400 $285 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $38.3 Million - $42.4 Million	666,900 Added 23.14%	3,549,100 $214 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $22.3 Million - $26.1 Million	407,400 Added 16.46%	2,882,200 $169 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $36 Million - $52.2 Million	774,800 Added 45.58%	2,474,800 $138 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $83.7 Million - $109 Million	1,700,000 New	1,700,000 $109 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $57.5 Million - $68.2 Million	-1,345,200 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $6.7 Million - $7.41 Million	150,200 Added 12.57%	1,345,200 $61 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $31.1 Million - $37.1 Million	689,100 Added 136.21%	1,195,000 $57 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $74.1 Million - $96.1 Million	-1,519,900 Reduced 75.03%	505,900 $26.3 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $19.6 Million - $22.1 Million	-354,500 Reduced 14.89%	2,025,800 $126 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $65.4 Million - $81.6 Million	-1,295,000 Reduced 35.24%	2,380,300 $132 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $179 Million - $206 Million	2,987,300 Added 434.2%	3,675,300 $232 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $11.2 Million - $12.2 Million	-186,700 Reduced 21.34%	688,000 $42.2 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $48.3 Million - $55.8 Million	874,700	874,700 $55.8 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Account